Federation des caisses Desjardins du Quebec’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.07M	Sell	26,930 -12,461	-32%	-$973K	0.01%	740
2025 Q4	$3.11M	Buy	39,391 +221	+0.6%	+$19.1K	0.01%	578
2025 Q3	$3.59M	Buy	39,170 +7,695	+24%	+$627K	0.01%	513
2025 Q2	$2.06M	Buy	31,475 +7,200	+30%	+$469K	0.01%	653
2025 Q1	$1.63M	Buy	24,275 +3,225	+15%	+$193K	0.01%	680
2024 Q4	$1.16M	Buy	21,050 +1,500	+8%	+$86.1K	0.01%	762
2024 Q3	$1.17M	Hold	19,550	–	–	0.01%	749
2024 Q2	$1.24M	Sell	19,550 -1,600	-8%	-$104K	0.01%	699
2024 Q1	$1.17M	Hold	21,150	–	–	0.01%	675
2023 Q4	$1.17M	Hold	21,150	–	–	0.01%	580
2023 Q3	$1.23M	Buy	21,150 +3,200	+18%	+$185K	0.01%	526
2023 Q2	$966K	Hold	17,950	–	–	0.01%	615
2023 Q1	$713K	Buy	+17,950	New	+$757K	0.01%	677
2022 Q4	–	Sell	-17,800	Closed	-$572K	–	2483
2022 Q3	$572K	Buy	17,800 +1,800	+11%	+$61.6K	0.01%	734
2022 Q2	$475K	Hold	16,000	–	–	0.01%	804
2022 Q1	$450K	Hold	16,000	–	–	﹤0.01%	874
2021 Q4	$737K	Buy	16,000 +10,849	+211%	+$466K	0.01%	746
2021 Q3	$169K	Buy	+5,151	New	+$160K	﹤0.01%	1216
2020 Q4	–	Sell	-38,850	Closed	-$1.1M	–	2326
2020 Q3	$1.1M	Hold	38,850	–	–	0.02%	540
2020 Q2	$1.26M	Buy	38,850 +4,150	+12%	+$149K	0.02%	491
2020 Q1	$1.43M	Buy	34,700 +15,700	+83%	+$835K	0.03%	432
2019 Q4	$1.17M	Buy	19,000 +3,000	+19%	+$199K	0.02%	615
2019 Q3	$1.17M	Hold	16,000	–	–	0.02%	602
2019 Q2	$1.31M	Buy	16,000 +9,017	+129%	+$641K	0.02%	556
2019 Q1	$492K	Buy	+6,983	New	+$411K	0.01%	744